Cholbam
Payments companies reported to CMS as associated with Cholbam. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cholbam, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cholbam
These are the largest totals companies reported as associated with Cholbam. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Joseph Ray | Galveston, TX | Clinical Genetics (M.D.) | $74,202.41 |
| Paul Hillman | Houston, TX | Clinical Genetics (M.D.) | $48,356.52 |
| Yasushi Kisanuki | Gahanna, OH | Neurology (Psychiatry & Neurology) | $46,800.64 |
| Edwin Ferren | Charlotte, NC | Pediatrics | $26,908.80 |
| Robert Steiner | Madison, WI | Clinical Genetics (M.D.) | $26,674.56 |
| Sirish Palle | Hyden, KY | Pediatrics | $22,164.25 |
| Zineb Ammous | Topeka, IN | Clinical Genetics (M.D.) | $16,266.71 |
| Ryan Himes | New Orleans, LA | Pediatric Gastroenterology | $15,562.83 |
| Janaina Anderson | Charleston, SC | Pediatric Gastroenterology | $15,031.87 |
| Vikram Prakash | Orlando, FL | Neurology With Special Qualifications In Child Neurology | $14,086.21 |
Prescribed Cholbam?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.